{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:30:55Z","timestamp":1780576255602,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Breakpoints to define the susceptibility of pathogens to antibiotics are becoming increasingly popular as guidance for antimicrobial therapy. Some breakpoints consider divergent concentrations of antibiotics in different compartments, others list one breakpoint for infections at all sites. Compared to the determination of exact minimal inhibitory concentrations (MICs) and relation of these MICs to concentrations achievable in ventricular CSF, the exclusive use of breakpoints for central nervous system (CNS) infections is a setback. The lack of the determination of exact MICs may be a risk, particularly when no clinical breakpoints for CNS infections have been defined. Moreover, the current practice of MIC determination of \u03b2-lactam\/\u03b2-lactamase inhibitor combinations with fixed \u03b2-lactamase inhibitor concentrations ignores that often these \u03b2-lactamase inhibitor concentrations are not attained in CSF with established antibiotic regimens. In CNS infections, we strongly recommend the exact determination of MICs and their interpretation in relation to the true antibiotic concentrations in the infected compartment.<\/jats:p>","DOI":"10.1007\/s15010-025-02678-7","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:06:47Z","timestamp":1762506407000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antibacterial therapy in central nervous system infections \u2013 breakpoints versus minimal inhibitory concentrations related to body fluid levels"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8316-995X","authenticated-orcid":false,"given":"Roland","family":"Nau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Seele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utz","family":"Reichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"S\u00f6rgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"2678_CR1","unstructured":"Davson H, Welch K, Segal MB. Physiology and pathophysiology of the cerebrospinal fluid. Edinburgh \u2013 London: Churchill Livingstone. 1987."},{"issue":"2","key":"2678_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJMra0804573","volume":"362","author":"D van de Beek","year":"2010","unstructured":"van de Beek D, Drake JM, Tunkel AR. Nosocomial bacterial meningitis. N Engl J Med. 2010;362(2):146\u201354. https:\/\/doi.org\/10.1056\/NEJMra0804573.","journal-title":"N Engl J Med"},{"issue":"1","key":"2678_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cmi.2019.05.016","volume":"26","author":"J Bodilsen","year":"2020","unstructured":"Bodilsen J, Dalager-Pedersen M, van de Beek D, Brouwer MC, Nielsen H. Incidence and mortality of brain abscess in denmark: a nationwide population-based study. Clin Microbiol Infect. 2020;26(1):95\u2013100. https:\/\/doi.org\/10.1016\/j.cmi.2019.05.016.","journal-title":"Clin Microbiol Infect"},{"key":"2678_CR4","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/cid\/ciaf071","volume":"80","author":"AJ Hsu","year":"2025","unstructured":"Hsu AJ, Chiotos K, Heil EL, Shields RK, Tamma PD. The effectiveness of newer Beta-Lactams for the treatment of Antimicrobial-Resistant Gram-Negative meningitis. Clin Infect Dis. 2025;80:959\u201368. https:\/\/doi.org\/10.1093\/cid\/ciaf071.","journal-title":"Clin Infect Dis"},{"key":"2678_CR5","unstructured":"Clinical & Laboratory Standards Institute (CLSI). https:\/\/em100.edaptivedocs.net\/GetDoc.aspx?doc=CLSI%20M100%20ED35:2025&sbssok=CLSI+M100+ED35%3a2025+TABLE+2A-1&format=HTML#CLSI%20M100%20ED35:2025%20TABLE%202A-1. Accesseded 18 July 2025."},{"key":"2678_CR6","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 15.0, valid from 2025-01-01. https:\/\/www.eucast.org. Accessed 18 February 2025."},{"key":"2678_CR7","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1128\/CMR.00007-10","volume":"23","author":"R Nau","year":"2010","unstructured":"Nau R, S\u00f6rgel F, Eiffert H. Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev. 2010;23:858\u201383.","journal-title":"Clin Microbiol Rev"},{"key":"2678_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1146\/annurev-pathol-051217-111018","volume":"13","author":"BA Plog","year":"2018","unstructured":"Plog BA, Nedergaard M. The glymphatic system in central nervous system health and disease: Past, Present, and future. Annu Rev Pathol. 2018;13:379\u201394. https:\/\/doi.org\/10.1146\/annurev-pathol-051217-111018.","journal-title":"Annu Rev Pathol"},{"key":"2678_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/bja\/aes216","volume":"109","author":"N Notkina","year":"2012","unstructured":"Notkina N, Dahyot-Fizelier C, Gupta AK. In vivo Microdialysis in Pharmacological studies of antibacterial agents in the brain. Br J Anaesth. 2012;109:155\u201360. https:\/\/doi.org\/10.1093\/bja\/aes216.","journal-title":"Br J Anaesth"},{"key":"2678_CR10","doi-asserted-by":"publisher","first-page":"e0181524","DOI":"10.1128\/aac.01815-24","volume":"69","author":"JM Guldb\u00e6k","year":"2025","unstructured":"Guldb\u00e6k JM, Mariager T, Nielsen MD, Terkelsen JH, Nau R, Bjarkam CR, Nielsen H, Bodilsen J. Distribution of ganciclovir in the Porcine central nervous system. Antimicrob Agents Chemother. 2025;69:e0181524.","journal-title":"Antimicrob Agents Chemother"},{"key":"2678_CR11","doi-asserted-by":"publisher","first-page":"e0181124","DOI":"10.1128\/aac.01811-24","volume":"69","author":"T Mariager","year":"2025","unstructured":"Mariager T, Terkelsen JH, Guldb\u00e6k JM, Nielsen MD, Vestergaard J, Bue M, \u00d6brink-Hansen K, Nau R, Bjarkam CR, de Lange ECM, Nielsen H, Bodilsen J. Distribution of acyclovir in central nervous system compartments: a Porcine Pharmacokinetic model. Antimicrob Agents Chemother. 2025;69:e0181124. https:\/\/doi.org\/10.1128\/aac.01811-24.","journal-title":"Antimicrob Agents Chemother"},{"key":"2678_CR12","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJM197512112932401","volume":"293","author":"AB Kaiser","year":"1975","unstructured":"Kaiser AB, McGee ZA. Aminoglycoside therapy of gram-negative bacillary meningitis. N Engl J Med. 1975;293:1215\u201320.","journal-title":"N Engl J Med"},{"key":"2678_CR13","doi-asserted-by":"publisher","first-page":"e00190","DOI":"10.1128\/CMR.00190-19","volume":"33","author":"R Nau","year":"2020","unstructured":"Nau R, Blei C, Eiffert H. Intrathecal antibacterial and antifungal therapies. Clin Microbiol Rev. 2020;33:e00190\u201319. https:\/\/doi.org\/10.1128\/CMR.00190-19.","journal-title":"Clin Microbiol Rev"},{"key":"2678_CR14","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1128\/AAC.30.3.481","volume":"30","author":"JS Bakken","year":"1986","unstructured":"Bakken JS, Bruun JN, Gaustad P, Tasker TC. Penetration of amoxicillin and potassium clavulanate into the cerebrospinal fluid of patients with inflamed meninges. Antimicrob Agents Chemother. 1986;30:481\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"2678_CR15","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1128\/AAC.41.5.987","volume":"41","author":"R Nau","year":"1997","unstructured":"Nau R, Kinzig-Schippers M, S\u00f6rgel F, Schinschke S, R\u00f6ssing R, M\u00fcller C, Kolenda H, Prange HW. Kinetics of Piperacillin and Tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients. Antimicrob Agents Chemother. 1997;41:987\u201391.","journal-title":"Antimicrob Agents Chemother"},{"key":"2678_CR16","doi-asserted-by":"publisher","first-page":"e01698","DOI":"10.1128\/AAC.01698-20","volume":"65","author":"FB Sime","year":"2020","unstructured":"Sime FB, Lassig-Smith M, Starr T, Stuart J, Pandey S, Parker SL, et al. Cerebrospinal fluid penetration of Ceftolozane-Tazobactam in critically ill patients with an indwelling external ventricular drain. Antimicrob Agents Chemother. 2020;65:e01698\u201320.","journal-title":"Antimicrob Agents Chemother"},{"key":"2678_CR17","doi-asserted-by":"publisher","first-page":"faa349","DOI":"10.1093\/ofid\/ofaa349","volume":"7","author":"M Yasmin","year":"2020","unstructured":"Yasmin M, Hanrahan J, Marshall S, Lodise TP, Chen L, Perez F, et al. Using therapeutic drug monitoring to treat KPC-Producing Klebsiella pneumoniae central nervous system infection with Ceftazidime\/Avibactam. Open Forum Infect Dis. 2020;7:faa349. https:\/\/doi.org\/10.1093\/ofid\/ofaa349.","journal-title":"Open Forum Infect Dis"},{"key":"2678_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jgar.2024.03.003","volume":"37","author":"L Volpicelli","year":"2024","unstructured":"Volpicelli L, Cairoli S, Al Ismail D, Baisi F, Sacco F, Goffredo BM, et al. Simultaneous post-neurosurgical ventriculitis and bacteraemia by two different strains of KPC-producing K. pneumoniae successfully treated with meropenem\/vaborbactam and high dose of fosfomycin. J Glob Antimicrob Resist. 2024;37:86\u201390.","journal-title":"J Glob Antimicrob Resist"},{"key":"2678_CR19","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/infdis\/149.4.568","volume":"149","author":"MG T\u00e4uber","year":"1984","unstructured":"T\u00e4uber MG, Doroshow CA, Hackbarth CJ, Rusnak MG, Drake TA, Sande MA. Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae. J Infect Dis. 1984;149:568\u201374.","journal-title":"J Infect Dis"},{"key":"2678_CR20","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/515003","volume":"27","author":"I Lutsar","year":"1998","unstructured":"Lutsar I, McCracken GH, Friedland IR. Antibiotic pharmacodynamics in cerebrospinal fluid. Clin Infect Dis. 1998;27:1117\u201327.","journal-title":"Clin Infect Dis"},{"key":"2678_CR21","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/jac\/dkx427","volume":"73","author":"JW Mouton","year":"2018","unstructured":"21, Mouton JW, Muller AE, Canton R, Giske CG, Kahlmeter G, Turnidge J. MIC-based dose adjustment: facts and fables. J Antimicrob Chemother. 2018;73:564\u201368. https:\/\/doi.org\/10.1093\/jac\/dkx427.","journal-title":"J Antimicrob Chemother"},{"key":"2678_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ebiom.2017.07.002","volume":"22","author":"V Nizet","year":"2017","unstructured":"Nizet V. The accidental orthodoxy of Drs. Mueller and Hinton. EBioMedicine. 2017;22:26\u20137. https:\/\/doi.org\/10.1016\/j.ebiom.2017.07.002.","journal-title":"EBioMedicine"},{"key":"2678_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ebiom.2017.05.026","volume":"20","author":"SC Ersoy","year":"2017","unstructured":"Ersoy SC, Heithoff DM, Barnes L 5th, Tripp GK, House JK, Marth JD, Smith JW, Mahan MJ. Correcting a fundamental flaw in the paradigm for antimicrobial susceptibility testing. EBioMedicine. 2017;20:173\u201381. https:\/\/doi.org\/10.1016\/j.ebiom.2017.05.026.","journal-title":"EBioMedicine"},{"issue":"12","key":"2678_CR24","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3390\/antibiotics13121215","volume":"13","author":"JS Wirth","year":"2024","unstructured":"Wirth JS, Djukic M, Biesner K, Reichard U, Nau R, Seele J. Increased antibiotic susceptibility of Gram-Positive bacteria in cerebrospinal fluid compared to broth. Antibiot (Basel). 2024;13(12):1215.","journal-title":"Antibiot (Basel)"},{"key":"2678_CR25","doi-asserted-by":"crossref","unstructured":"Biesner K, Djukic M, Reichard U, Nau R, Seele J. Antibiotic susceptibility of Gram-negative bacteria in cerebrospinal fluid compared to Mueller-Hinton broth and artificial cerebrospinal fluid. Abstract, ESCMID Global 2025, Vienna, Austria, April 12\u201315, 2025.","DOI":"10.1016\/j.ijantimicag.2026.107730"},{"key":"2678_CR26","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.2215\/CJN.08140718","volume":"14","author":"RF Eyler","year":"2019","unstructured":"Eyler RF, Shvets K. Clinical Pharmacology of antibiotics. Clin J Am Soc Nephrol. 2019;14:1080\u201390. https:\/\/doi.org\/10.2215\/CJN.08140718.","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02678-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-025-02678-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02678-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T07:36:25Z","timestamp":1779262585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-025-02678-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2678"],"URL":"https:\/\/doi.org\/10.1007\/s15010-025-02678-7","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"17 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}